|
Colorectal cancer Articles
Colorectal cancer News : Colorectal Cancer Association of Canada Launches its Second Annual Public Service Announcement Contest Fri, 03 Sep 2010 14:01:00 GMT en/ccac/colorectal-cancer-association-launches-contestColorectal cancer News : Osteoporosis Drugs May Be Linked to Cancer Risk Sat, 04 Sep 2010 07:30:13 GMT Title: Osteoporosis Drugs May Be Linked to Cancer Risk Category: Health News Created: 9/3/2010 8:58:00 AM Last Editorial Review: 9/3/2010 8:58:19 AMOsteoporosis drug linked to cancer Sat, 04 Sep 2010 00:45:56 GMT OXFORD, England, Sept. 3 (UPI) -- Long-term use of oral bisphosphonates -- used to prevent bone loss -- may double the risk of developing esophageal cancer, researchers in Britain say. Osteoporosis - Esophageal cancer - Health - Cancer - EnglandIn Lung Cancer, Tumor Budding Identified As Predictor For Unfavorable Outcome Fri, 03 Sep 2010 10:42:51 GMT Lung cancer is the leading cause of cancer deaths worldwide, and the prognosis is generally poor, even if surgery is successful. Furthermore, the incidence of one type of lung cancer, adenocarcinoma, has been increasing in recent years. A better understanding of the changes in tumor cell biology that result in a more aggressive neoplastic phenotype (characteristic of an abnormal mass of tissue ...Long Term Use Of Oral Bisphosphonates May Double Risk Of Esophageal Cancer Sat, 04 Sep 2010 00:00:14 GMT Research: Oral bisphosphonates and risk of cancer of the esophagus, stomach and colorectum: Case-control analysis within a UK primary care cohortPeople who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published on bmj.com today.Oral bisphosphonates are a type of drug used to ...Bone-building drugs double the risk of esophageal cancer, but the risk is still small Fri, 03 Sep 2010 20:02:17 GMT The family of bone-building drugs that includes Fosamax, Actonel and Boniva can double the risk of developing throat cancer, researchers reported Thursday in the latest development in what has become a confusing discussion. Other studies have reported no increase, but even if the newest finding is correct, the risk is still quite small--about two cases per 1,000 people between age 60 and 79 ...Metformin May Protect Against Lung Cancer Fri, 03 Sep 2010 20:27:00 GMT Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors and possibly colorectal tumors, according to two studies published in Cancer Prevention Research.Diabetes 2 Drug Metformin May Protect Against Lung Cancer In Smokers Thu, 02 Sep 2010 16:11:47 GMT Two studies reveal that smokers may have a significantly lower risk of developing lung cancer and colorectal cancer with the drug metformin, which is commonly prescribed for diabetes type 2 treatment, the medical journal Cancer Prevention Research informs. Metformin, originally sold as Glucophage, is the first-line drug of choice for diabetes type 2 patients, especially those who are obese or ...New lung cancer drug Fri, 03 Sep 2010 03:27:36 GMT A newly funded lung cancer drug will allow patients more freedom when getting treatment.Common bone drugs linked to esophageal cancer risk Sat, 04 Sep 2010 04:40:46 GMT LONDON (Reuters) - People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of developing cancer of the gullet or esophagus, a British study found on Friday.Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice Fri, 03 Sep 2010 07:29:02 GMT Title: Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice Category: Health News Created: 9/1/2010 2:10:00 PM Last Editorial Review: 9/2/2010Study Raises New Questions About Bone Drugs, Cancer Risk Fri, 03 Sep 2010 14:51:28 GMT Osteoporosis drugs like Actonel, Boniva, and Fosamax could double the risk of esophageal cancer if they are used over a long period of time, according to the findings from a new study. The research, which was funded by Britain’s Medical Research Council and Cancer Research UK, was published today in the British Medical Journal. Actonel, [...]Long-Term Use of Bone Drugs May Be Linked to Esophageal Cancer Thu, 02 Sep 2010 23:08:12 GMT THURSDAY, Sept. 2 (HealthDay News) -- People with osteoporosis who take drugs such as Boniva (ibandronate), Fosamax (alendronate) or Actonel (risedronate) to strengthen their bones may be at an increased risk of esophageal cancer, British researchers report.New lung cancer drug funded in multi-product deal Thu, 02 Sep 2010 22:28:55 GMT Funding a new drug for people with advanced lung cancer and widening access to two other cancer treatments are features of a new agreement PHARMAC has reached with pharmaceutical company Roche Products (NZ) Ltd.Capsaicin linked to skin cancer Fri, 03 Sep 2010 05:27:12 GMT The September cover story of the nation's leading cancer journal, "Cancer Research," features a new study from The Hormel Institute, University of Minnesota, that links capsaicin, a component of chili peppers, to skin cancer. While the molecular mechanisms of the cancer-promoting effects of capsaicin are not clear and remain controversial, The Hormel Institute has shown a definite connection to ...Diabetes drug can reduce risk of cancer, researchers find Thu, 02 Sep 2010 16:35:55 GMT Metformin reduced the development of lung tumors in mice by more than 70%. Clinical trials on humans for lung, breast and prostate cancer are being organized. A growing body of evidence suggests that the widely used diabetes drug metformin can reduce the risk of cancer, researchers said Wednesday.Study finds education strategies vital to address breast cancer in Mexican-origin women Fri, 03 Sep 2010 08:42:22 GMT Specific prevention and education strategies are needed to address breast cancer in Mexican-origin women in this country, according to a study at The University of Texas MD Anderson Cancer Center, which was published online in the journal Cancer.Osteoporosis Drugs May Be Linked to Cancer Risk Thu, 02 Sep 2010 23:30:07 GMT The long-term use of oral bisphosphonate osteoporosis drugs such as Actonel, Boniva, and Fosamax may be associated with a doubling in esophageal cancer risk, but the risk to individual users remains small, researchers say.Radient Pharmaceuticals Resumes Collaboration To Advance Its Onko-Sure® In Vitro Diagnostic Cancer Test In The USA Thu, 02 Sep 2010 14:22:32 GMT Radient Pharmaceuticals Corporation (RPC) /quotes/comstock/14*!rpc/quotes/nls/rpc (RPC 0.68, +0.00, +0.03%) announced today it has resumed collaborations with Mayo Collaborative Services, Inc. to conduct a clinical study for the validation of RPC's US FDA-approved Onko-Sure(R) in vitro diagnostic (IVD) cancer test as a useful tool in colorectal cancer (CRC) recurrence and treatment monitoring.Common bone drugs linked to oesophageal cancer risk Thu, 02 Sep 2010 23:18:54 GMT Source: Reuters * Study is first to find gullet cancer link to long-term use * Bisphosphonates are widely prescribed for bone weakness * Patients should continue on drugs, watch for warning signs By Kate ...Common Osteoporosis Drug Linked To Higher Risk Of Oesophageal Cancer Fri, 03 Sep 2010 12:26:31 GMT A new UK study that followed a large number of people found that those who took 10 or more prescriptions for oral bisphosphonates, a group of drugs commonly used to treat the bone disease osteoporosis, were at higher risk of developing oesophageal cancer. You can read about the research behind this finding in a paper published online in the British Medical Journal, BMJ on 2 September...Common bone drugs linked to oesophageal cancer risk Thu, 02 Sep 2010 23:01:09 GMT * Study is first to find gullet cancer link to long-term useLong term use of oral bisphosphonates may double risk of esophageal cancer, study finds Fri, 03 Sep 2010 01:23:25 GMT People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing esophageal cancer (cancer of the gullet), according to a new study.Osteoporosis drug 'doubles cancer risk' Fri, 03 Sep 2010 06:43:56 GMT London, Sep 03 : A new study has shown that people who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet).Long term use of oral bisphosphonates may double risk of esophageal cancer Thu, 02 Sep 2010 23:31:59 GMT People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing esophageal cancer (cancer of the gullet), according to a new study published on bmj.com today.Cancer Victim's Dream Comes True Mon, 30 Aug 2010 22:28:39 GMT A man battling colorectal cancer is granted his wish of becoming a deputy.Long term use of oral bisphosphonates may double risk of esophageal cancer Thu, 02 Sep 2010 23:32:19 GMT People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published in the British Medical Journal today.Can Fruits, Veggies Help Ward Off Lung Cancer? Thu, 02 Sep 2010 07:28:52 GMT Title: Can Fruits, Veggies Help Ward Off Lung Cancer? Category: Health News Created: 8/31/2010 12:10:00 PM Last Editorial Review: 9/1/2010Fat caused 124,000 cancer cases in Europe: Experts Thu, 02 Sep 2010 09:00:59 GMT More than 124,000 people in Europe developed cancer last year because they are overweight, and rising body fat levels threaten to add tens of thousands more to their ranks, experts say.Citing clinical evidence, coalition urges U.S. panel to approve CT colonography for screening Fri, 03 Sep 2010 21:43:42 GMT A growing body of evidence supports the use of CT colonography for colon cancer screening and a U.S. panel should reverse its decision to not endorse the procedure, according to the CT Colonography Coalition.Diabetes Drug Metformin Linked to Lower Lung Cancer Rate in Mice Wed, 01 Sep 2010 18:03:23 GMT WEDNESDAY, Sept. 1 (HealthDay News) -- A drug widely used to treat high blood sugar in type 2 diabetics may hold some promise in the prevention of tobacco-induced lung cancer, according to extremely preliminary findings in a mouse study.Diabetes drug metformin found to reduce cancer risk Thu, 02 Sep 2010 07:56:29 GMT http://www.JewishWorldReview.com | (MCT) A growing body of evidence suggests that the widely used diabetes drug metformin can reduce the risk of cancer, researchers said Wednesday.Colonoscopy repeats greater with non-specialists Fri, 03 Sep 2010 20:07:19 GMT Older adults who have a colonoscopy performed by a family doctor, internist or general surgeon are somewhat more likely to need another one within a year compared with those who have the procedure done by a gastroenterologist, a new report finds.Anti-Cancer Gene To Be Activated By Researchers Wed, 01 Sep 2010 10:40:40 GMT Researchers at the Faculty of Health Sciences have succeeded in decoding the genetic key that gives particular intestinal cells their identity. With this knowledge of the complex network of genes the researchers now hope to stop colon cancer by activating special anti-cancer genes. Colon sloughs lining The intestines have to work properly if we are to benefit from the food we eat. Digestive ...Tumor budding identified as predictor for unfavorable outcome in lung cancer Wed, 01 Sep 2010 13:22:35 GMT Lung cancer is the leading cause of cancer deaths worldwide, and the prognosis is generally poor, even if surgery is successful. Furthermore, the incidence of one type of lung cancer, adenocarcinoma, has been increasing in recent years.Dr. Oz Has Colon Cancer Scare Wed, 01 Sep 2010 15:29:01 GMT Dr. Mehmet Oz had a cancer scare, FOX Chicago News has learned.Dr. Oz Has Colon Cancer Scare Wed, 01 Sep 2010 15:14:03 GMT Dr. Mehmet Oz had a cancer scare, FO X Chicago News has learned.GeneNews Expected to Debut ColonSentry in New York by Year's End Wed, 01 Sep 2010 15:10:04 GMT GeneNews is expected to debut in its ColonSentry colorectal cancer screening LDT in New York State either by the end of the year or within the first three months of 2011, according to an equities analyst.EmpowHER Offers FREE Resources and Support to Women Living With Ovarian Cancer Wed, 01 Sep 2010 21:45:59 GMT Early Diagnoses of Ovarian Cancer Can Lead to a 93 Percent Survival Rate in Women in the United StatesDiabetes drug shows potential as a cancer fighter Wed, 01 Sep 2010 20:20:55 GMT An inexpensive drug that's already used to treat type 2 diabetes could find new life as a cancer fighter, with two new studies suggesting it fights off colon cancer and even prevents lung cancer in smokers.2.6 million Chinese hit by cancer annually Wed, 01 Sep 2010 01:54:54 GMT BEIJING: The cancer mortality rate in China has increased by 80 percent over the past 30 years, and it is reported that some 1.8 million cancer-related deaths occur annually, Qatar News agency reported, citing Health Minister Chen Zhu as saying.Consuming variety of fruits, vegetables may decrease squamous cell lung cancer risk: Study Thu, 02 Sep 2010 05:13:02 GMT Adding a variety of vegetables to one's diet may help decrease the chance of getting lung cancer, and adding a variety of fruits and vegetables may decrease the risk of squamous cell lung cancer, especially among smokers.Don’t be a fool, check your stool Thu, 02 Sep 2010 04:09:59 GMT A free colorectal screening will be held today at 1 p.m. at Lenoir Memorial Hospital. Those participating in the screening will receive a kit to perform the test in the comfort of their home, according to LMH Director of Community Programming...Chugai files Xeloda NDA with Japanese authority seeking nod for new indication to treat advanced or refractory gastric ... Fri, 03 Sep 2010 07:42:41 GMT Chugai Pharmaceutical Co., Ltd. announced that it filed a new drug application (NDA) on September 1, based on evidence in the public domain with the Japanese Ministry of Health, Labour and Welfare (MHLW), seeking approval for the indication "advanced or refractory gastric cancer in patients who are not candidates for curative surgery" for the anti-cancer agent capecitabine (brand name: Xeloda ...Asuragen's Clinical Laboratory Launches KRAS And BRAF Mutation Testing Fri, 03 Sep 2010 12:26:51 GMT Asuragen, Inc., a leader in molecular diagnostics and nucleic acid-based pharmacogenomics services, announced that it has launched KRAS and BRAF mutational testing services in its CAP-accredited CLIA laboratory. Asuragen's KRAS and BRAF laboratory developed tests (LDTs) were designed in response to newly modified guidelines from the American Society of Clinical Oncology (ASCO) and the National ...High-fat diet during puberty increases risk of breast cancer Thu, 02 Sep 2010 07:27:22 GMT Girls eating a high-fat diet during puberty, even those who do not become overweight or obese, may be at a greater risk of developing breast cancer later in life, according to Michigan State University researchers.MSKCC develops new prediction tool to calculate risk for DCIS recurrence after breast-conserving surgery Sat, 04 Sep 2010 04:28:22 GMT The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.Medicare Now Helps Smokers Quit Sat, 04 Sep 2010 05:03:01 GMT The Affordable Care Act is bringing hope to those Americans who want to quit smoking.Metformin may protect against lung cancer Wed, 01 Sep 2010 19:16:59 GMT Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute (NCI). |
Infectious and parasitic diseases |
|
|
< Home > |
||